Cargando…

Survival Outcomes of Patients Treated with Hypofractionated Stereotactic Body Radiation Therapy for Parotid Gland Tumors: a Retrospective Analysis

Background: to review a single-institution experience with the management of parotid malignancies treated by fractionated stereotactic body radiosurgery (SBRT). Findings: Between 2003 and 2011, 13 patients diagnosed with parotid malignancies were treated with adjuvant or definitive SBRT to a median...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karam, Sana D., Snider, James W., Wang, Hongkun, Wooster, Margaux, Lominska, Christopher, Deeken, John, Newkirk, Kenneth, Davidson, Bruce, Harter, K. William
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Research Foundation 2012
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364484/ https://www.ncbi.nlm.nih.gov/pubmed/22666661 http://dx.doi.org/10.3389/fonc.2012.00055

Ejemplares similares

Reirradiation of recurrent salivary gland malignancies with fractionated stereotactic body radiation therapy
por: Karam, Sana D., et al.
Publicado: (2012)

IMRT with Stereotactic Body Radiotherapy Boost for High Risk Malignant Salivary Gland Malignancies: A Case Series
por: Karam, Sana D., et al.
Publicado: (2014)

The use of stereotactic body radiation therapy for local control of glomangiomatosis: a case report
por: Horne, Zachary D., et al.
Publicado: (2013)

Low Incidence of Fatigue after Hypofractionated Stereotactic Body Radiation Therapy for Localized Prostate Cancer
por: Dash, Chiranjeev, et al.
Publicado: (2012)

Usefulness of Stereotactic Body Radiation Therapy for Treatment of Adrenal Gland Metastases
por: Scouarnec, Cyrielle, et al.
Publicado: (2019)

Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer
por: Ju, Andrew W, et al.
Publicado: (2013)

Stereotactic Body Radiotherapy for Treatment of Squamous Cell Carcinoma of the Tongue Associated with Human Papilloma Virus: A Case Report
por: Rodgers, Brian, et al.
Publicado: (2013)

Contouring the accessory parotid gland and major parotid glands as a single organ at risk during nasopharyngeal carcinoma radiotherapy
por: Cai, Xin-Ling, et al.
Publicado: (2022)

Hypofractionated Radiation Therapy for Large Brain Metastases
por: Masucci, Giuseppina Laura
Publicado: (2018)

Role of Hyperbaric Oxygenation Plus Hypofractionated Stereotactic Radiotherapy in Recurrent High-Grade Glioma
por: Arpa, Donatella, et al.
Publicado: (2021)

Vestibular Schwannoma: Results of Hypofractionated Stereotactic Radiation Therapy
por: Pialat, Pierre-Marie, et al.
Publicado: (2021)

Stereotactic body radiation therapy for reirradiation of localized adenocarcinoma of the pancreas
por: Lominska, Chris E, et al.
Publicado: (2012)

A Case of Metastatic Head and Neck Squamous Cell Carcinoma with Multiple Treatments Including Stereotactic Ablative Body Radiotherapy Alone for Oligometastases to the Parotid Gland
por: Sharrett, Jonathan, et al.
Publicado: (2015)

Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy Cost-Effectiveness Results
por: Bijlani, Akash, et al.
Publicado: (2013)

Acute Cardiotoxicity With Concurrent Trastuzumab and Hypofractionated Radiation Therapy in Breast Cancer Patients
por: Sayan, Mutlay, et al.
Publicado: (2019)

Incorporation of Dosimetric Gradients and Parotid Gland Migration Into Xerostomia Prediction
por: Astaburuaga, Rosario, et al.
Publicado: (2019)

Hypofractionated stereotactic body radiation therapy for elderly patients with stage IIB–IV nonsmall cell lung cancer who are ineligible for or refuse other treatment modalities
por: Karam, Sana D, et al.
Publicado: (2014)

Normal tissue toxicity after small field hypofractionated stereotactic body radiation
por: Milano, Michael T, et al.
Publicado: (2008)

Reirradiation of head and neck cancer focusing on hypofractionated stereotactic body radiation therapy
por: Yamazaki, Hideya, et al.
Publicado: (2011)

Stereotactic body radiation therapy in the treatment of oligometastatic prostate cancer
por: Ahmed, Kamran A., et al.
Publicado: (2013)

Frameless Fractionated Stereotactic Radiosurgery for Vestibular Schwannomas: A Single-Institution Experience
por: Karam, Sana D., et al.
Publicado: (2013)

Long-term Treatment Response and Patient Outcomes for Vestibular Schwannoma Patients Treated with Hypofractionated Stereotactic Radiotherapy
por: Patel, Mira A., et al.
Publicado: (2017)

Outcomes of Hypofractionated Stereotactic Radiotherapy for Small and Moderate-Sized Brain Metastases: A Single-Institution Analysis
por: Yan, Michael, et al.
Publicado: (2022)

Intensity-Modulated Radiation Therapy with Stereotactic Body Radiation Therapy Boost for Unfavorable Prostate Cancer: The Georgetown University Experience
por: Mercado, Catherine, et al.
Publicado: (2016)

Case Report: Stereotactic body radiation treatment for immunotherapy escaped oligometastatic progression in cutaneous melanoma and merkel cell carcinoma
por: Khaddour, Karam, et al.
Publicado: (2023)

Volumetric modulated arc therapy treatment planning of thoracic vertebral metastases using stereotactic body radiotherapy
por: Mallory, Matthew, et al.
Publicado: (2018)

Hypofractionated Stereotactic Radiotherapy for Non-breast or Prostate Cancer Oligometastases: A Tail of Survival Beyond 10 Years
por: Aujla, Khush S., et al.
Publicado: (2019)

Pathologic Collision of Inverted Papilloma with Esthesioneuroblastoma
por: Karam, Sana D., et al.
Publicado: (2014)

Carcinosarcoma of parotid gland (malignant mixed tumor)
por: Feng, Duan, et al.
Publicado: (2015)

Parotid gland radiation dose‐xerostomia relationships based on actual delivered dose for nasopharyngeal carcinoma
por: Lou, Jingjiao, et al.
Publicado: (2018)

Intensity-Modulated Radiation Therapy with Stereotactic Body Radiation Therapy Boost for Unfavorable Prostate Cancer: A Report on 3-Year Toxicity
por: Paydar, Ima, et al.
Publicado: (2017)

Stereotactic Body Radiation Therapy for Prostate Cancer: What is the Appropriate Patient-Reported Outcome for Clinical Trial Design?
por: Woo, Jennifer Ai-Lian, et al.
Publicado: (2015)

CT-based radiomics with various classifiers for histological differentiation of parotid gland tumors
por: Lu, Yang, et al.
Publicado: (2023)

Innovative Hypofractionated Stereotactic Regimen Achieves Excellent Local Control with No Radiation Necrosis: Promising Results in the Management of Patients with Small Recurrent Inoperable GBM
por: Jia, Angela, et al.
Publicado: (2016)

Hypofractionated stereotactic radiation therapy for recurrent glioblastoma: single institutional experience
por: Ciammella, Patrizia, et al.
Publicado: (2013)

Macular hole and vitreous hemorrhage subsequent to stereotactic hypofractionated radiotherapy for choroidal melanoma: A case report and review of the literature
por: Zhou, Xiaoyin, et al.
Publicado: (2022)

Mild Hypofractionated Radiation Therapy for Merkel Cell Carcinoma
por: Matsui, Toshiaki, et al.
Publicado: (2020)

The Comparison of Stereotactic Body Radiation Therapy and Intensity-Modulated Radiation Therapy for Prostate Cancer by NCCN Risk Groups
por: Ricco, Anthony, et al.
Publicado: (2016)

AB013. Treatment of thymic oligometastastic or oligoprogressive lesions with hypofractionated radiation therapy or stereotactic body radiation therapy
por: Jackson, Christopher B., et al.
Publicado: (2022)

Influence of the Hypersensitivity to Low Dose Phenomenon on the Tumor Response to Hypofractionated Stereotactic Body Radiation Therapy
por: Le Reun, Eymeric, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cqckr7v7ih90f9hknsq7tigu4p